Cegla M - Search Results

1

Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity.

Heeres J, de Jonge MR, Koymans LM, Daeyaert FF, Vinkers M, Van Aken KJ, Arnold E, Das K, Kilonda A, Hoornaert GJ, Compernolle F, Cegla M, Azzam RA, Andries K, de Béthune MP, Azijn H, Pauwels R, Lewi PJ, Janssen PA. Heeres J, et al. Among authors: cegla m. J Med Chem. 2005 Mar 24;48(6):1910-8. doi: 10.1021/jm040829e. J Med Chem. 2005. PMID: 15771435

2

Synthesis and quantitative structure-activity relationship analysis of 2-(aryl or heteroaryl)quinolin-4-amines, a new class of anti-HIV-1 agents.

Strekowski L, Mokrosz JL, Honkan VA, Czarny A, Cegla MT, Wydra RL, Patterson SE, Schinazi RF. Strekowski L, et al. Among authors: cegla mt. J Med Chem. 1991 May;34(5):1739-46. doi: 10.1021/jm00109a031. J Med Chem. 1991. PMID: 2033597

3

Preliminary evaluation of pharmacological properties of some xanthone derivatives.

Marona H, Szkaradek N, Rapacz A, Filipek B, Dybała M, Siwek A, Cegła M, Szneler E. Marona H, et al. Among authors: cegla m. Bioorg Med Chem. 2009 Feb 1;17(3):1345-52. doi: 10.1016/j.bmc.2008.12.031. Epub 2008 Dec 24. Bioorg Med Chem. 2009. PMID: 19131251

4

Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone.

Szkaradek N, Rapacz A, Pytka K, Filipek B, Siwek A, Cegła M, Marona H. Szkaradek N, et al. Among authors: cegla m. Bioorg Med Chem. 2013 Jan 15;21(2):514-22. doi: 10.1016/j.bmc.2012.11.014. Epub 2012 Nov 24. Bioorg Med Chem. 2013. PMID: 23245804

5

Anticonvulsant evaluation of aminoalkanol derivatives of 2- and 4-methylxanthone.

Szkaradek N, Gunia A, Waszkielewicz AM, Antkiewicz-Michaluk L, Cegła M, Szneler E, Marona H. Szkaradek N, et al. Among authors: cegla m. Bioorg Med Chem. 2013 Mar 1;21(5):1190-8. doi: 10.1016/j.bmc.2012.12.051. Epub 2013 Jan 9. Bioorg Med Chem. 2013. PMID: 23375095

6

N-[(2,6-Dimethylphenoxy)alkyl]aminoalkanols-their physicochemical and anticonvulsant properties.

Waszkielewicz AM, Cegła M, Żesławska E, Nitek W, Słoczyńska K, Marona H. Waszkielewicz AM, et al. Among authors: cegla m. Bioorg Med Chem. 2015 Aug 1;23(15):4197-4217. doi: 10.1016/j.bmc.2015.06.045. Epub 2015 Jun 27. Bioorg Med Chem. 2015. PMID: 26164622

7

Structure-activity relationship studies of central nervous system agents. 5. Effect of the hydrocarbon chain on the affinity of 4-substituted 1-(3-chlorophenyl)piperazines for 5-HT1A receptor site.

Mokrosz JL, Pietrasiewicz M, Duszyńska B, Cegła MT. Mokrosz JL, et al. Among authors: cegla mt. J Med Chem. 1992 Jun 26;35(13):2369-74. doi: 10.1021/jm00091a004. J Med Chem. 1992. PMID: 1535661

8

Studies on novel pyridine and 2-pyridone derivatives of N-arylpiperazine as α-adrenoceptor ligands.

Baran M, Kepczyńska E, Zylewski M, Siwek A, Bednarski M, Cegła MT. Baran M, et al. Among authors: cegla mt. Med Chem. 2014 Mar;10(2):144-53. doi: 10.2174/0929867320999131122114922. Med Chem. 2014. PMID: 23627274

9

Chiral discrimination in binding of enantiomers of 2-(aminoalkoxy)-substituted 4-(2-thienyl)pyrimidines and 4,6-bis(2-thienyl)pyrimidines with duplex DNA.

Strekowski L, Cegla MT, Honkan V, Buczak H, Winkeljohn WR, Baumstark AL, Wilson WD. Strekowski L, et al. Bioorg Med Chem Lett. 2005 Jun 2;15(11):2720-3. doi: 10.1016/j.bmcl.2005.04.004. Bioorg Med Chem Lett. 2005. PMID: 15878270

10

4-Aryl-1-piperazinylalkyl derivatives of 1,2,3,4-tetrahydro-beta-carboline ring system. Synthesis and preliminary in vivo studies.

Cegła MT, Boksa J, Chojnacka-Wójcik E, Misztal S. Cegła MT, et al. Pharmazie. 1996 Dec;51(12):932-6. Pharmazie. 1996. PMID: 8985983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters